~~<i id='77889B9FFB'><strike id='77889B9FFB'><tt id='77889B9FFB'><pre id='77889B9FFB'></pre></tt></strike></i>~~

Home» explore» focus

focus

author：Wikipedia 2025-08-14 16:14:07 Page View：4511

You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences. Sign up to get it delivered in your inbox every Tuesday and Thursday.

Diabetes: Better shows data on app’s benefit with GLP-1s

Better Therapeutics announced top-line data suggesting that its prescription app for diabetes treatment, AspyreRx, can boost the impact of GLP-1 diabetes treatments. According to the release, a subgroup analysis of 160 participants in its pivotal trial on GLP-1 treatment found that the behavior modification app produced statistically significant reductions in A1C compared to a control group.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Cholera vaccine supply gets boost as demand surges globally
Next article： In Memoriam: Notable people who died in 2023

explore

Malaria cases in Florida and Texas: Here’s what you need to know

MosquitoscaughtfortestingawaitshipmenttoalabinMcAllen,Texas,inApril2016tobetestedformosquito-bornedi

Getting Alzheimer's drug Leqembi to patients can be a challenge

BenMargot/APAhostofhurdlesareslowingtheadoptionofthenewAlzheimer’sdrugLeqembi,expertsinvolvedinthetr

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Duchennemusculardystrophyhistopathology.Dr.EdwinP.Ewing,Jr./CDCWhenIwasdiagnosedwithDuchennemuscular

Key Senate committee drafts bipartisan bill to stem drug shortages

AdobeWASHINGTON—TheSenateFinanceCommitteehasdraftedabipartisanbilltomitigatedrugshortagesbyrewarding